President Donald Trump is preparing to reintroduce a sweeping drug pricing plan that ties U.S. Medicare payments to prices in other countries. The expected executive order aims to revive the “most favored nation” (MFN) policy, which links the cost of select Medicare drugs to the lower prices paid by foreign governments.